Congratulations to Guo Rui Yinuo on winning the “High-end Talent Attraction and Development Award” and the “Benchmark Enterprise Award for Qin Chuangyuan Construction” in Xixian New Area’s Airport New City!
Release time:
2023-03-02 19:29
Keywords:
On February 27, 2023, the Airport New City in Xixian New Area held the 2022 Policy Implementation Conference for High-Quality Development of the Airport Economy, during which 139 enterprises that had made outstanding contributions to the high-quality economic and social development of the airport area were recognized. Xixian New Area Guorui Yinuo Drug Safety Evaluation and Research Co., Ltd. was awarded the "High-End Talent Attraction and Cultivation Award" and the "Qin Chuangyuan Construction Benchmark Enterprise Award."
Currently, Guorui Yinuo has identified one high-level talent in Xi'an City, one young talent under the Xi'an Yingcai Program, and one “Qin Chuang Yuan Innovation Talent – High-end Innovation Team.” We will continue to attract and cultivate top-tier talents to accelerate the rapid development of Guorui GLP’s business.
In 2022, Guorui Yinuo successfully obtained approval from the Xi'an Municipal Science and Technology Bureau for the “Qin Chuang Yuan Achievement Transformation ‘Accelerator’ Special Platform Project—a Non-Clinical Safety Evaluation Platform for Drugs Compliant with GLP Standards.” This project will better facilitate Qin Chuang Yuan’s role in integrating the innovation and industrial chains in the biopharmaceutical sector, opening up new horizons for our province’s biopharmaceutical industry.
Guorei Yinuo is dedicated to non-clinical safety evaluation of pharmaceuticals, offering clients a one-stop service that includes personalized protocol design, drug screening, pharmacodynamic studies, pharmacokinetic studies, safety assessments, and clinical trial sample analysis. The company also provides services for safety evaluations of foods, health supplements, cosmetics, and pesticides. In addition, Guorei Yinuo has established platforms for the development of disease-model animals and the breeding of laboratory animals. In July 2021, Guorei Yinuo obtained the GLP certification approval issued by the National Medical Products Administration; in August 2022, it successfully passed the GLP inspection conducted by the Ministry of Agriculture and Rural Affairs for veterinary drugs. Leveraging its unique strengths, Guorei Yinuo will continue to pursue GLP qualification accreditation across the entire pharmaceutical spectrum and has already initiated the process for international GLP certification.
Related News
Contact phone number
Ms. Li:+86 15760970681
Mr. Su:+86 19991001701
Landline:+86-29-33656828
Company Address
4th Floor, Unit C. Building 9. Small and Medium-sized
Enterprise Park, Airport Industrial Zone Airport New Ciy,Xixian New Area, Shaanxi Province
©2026 Xixian New Area Guorui Yinuo Drug Safety Evaluation and Research Co., Ltd.
WhatsApp：8613940397353
Email：hr-xian@grglp.com
Landline：862933656828
Mr. Su：8619991001701
Ms. Li：8615760970681